CasLoc logo
All Cases PTAB Litigations UPC Oppositions

NOVARTIS PHARMACEUTICALS CORPORATION v. SAGENT PHARMACEUTICALS, INC.

2:14-cv-07556

Overview

Case Number 2:14-cv-07556
Filing Date 2014-12-03
Status Terminated
Termination Date 2015-12-02
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Movant

SAGENT PHARMACEUTICALS, INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Defendant

NOVARTIS PHARMACEUTICALS CORPORATION Operating Company

Represented By

1 Attorneys Listed

WILLIAM J. O'SHAUGHNESSY

MCCARTER & ENGLISH, LLP

Tel: +1 (973) 622-4444

FOUR GATEWAY CENTER, 100 MULBERRY STREET

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Docket Entries

(10 total)
Pleading / Complaint

COMPLAINT against SAGENT PHARMACEUTICALS, INC. ( Filing and Admin fee $ 400 receipt number 0312-6082151), filed by NOVARTIS PHARMACEUTICALS CORPORATION. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A)(anr) (Entered: 12/05/2014)

Entry #1 • 2014-12-03
1
Pleading / Complaint

COMPLAINT against SAGENT PHARMACEUTICALS, INC. ( Filing and Admin fee $ 400 receipt number 0312-6082151), filed by NOVARTIS PHARMACEUTICALS CORPORATION. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A)(anr) (Entered: 12/05/2014)

Entry #1 • 2014-12-03
2
Pleading / Complaint

COMPLAINT against SAGENT PHARMACEUTICALS, INC. ( Filing and Admin fee $ 400 receipt number 0312-6082151), filed by NOVARTIS PHARMACEUTICALS CORPORATION. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A)(anr) (Entered: 12/05/2014)

Entry #1 • 2014-12-03
2

Corporate Disclosure Statement by NOVARTIS PHARMACEUTICALS CORPORATION identifying NOVARTIS AG as Corporate Parent. (anr) (Entered: 12/05/2014)

Entry #2 • 2014-12-03
1
Pleading / Complaint

AO120 Patent/Trademark Form filed. (Attachments: # 1 COMPLAINT, # 2 EXHIBIT) (anr) (Entered: 12/05/2014)

Entry #3 • 2014-12-03
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc